Avantor, Inc. (AVTR)
14.54
-0.04
(-0.27%)
USD |
NYSE |
Aug 31, 16:00
14.54
0.00 (0.00%)
Pre-Market: 20:00
Avantor Cash from Operations (Annual) : 623.80M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 623.80M |
| December 31, 2024 | 840.80M |
| December 31, 2023 | 870.00M |
| December 31, 2022 | 843.60M |
| December 31, 2021 | 953.60M |
| December 31, 2020 | 929.80M |
| Date | Value |
|---|---|
| December 31, 2019 | 354.00M |
| December 31, 2018 | 200.50M |
| December 31, 2017 | -167.50M |
| December 31, 2016 | 72.90M |
| December 31, 2015 | 124.60M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Medpace Holdings, Inc. | 713.22M |
| Champions Oncology, Inc. | -4.472M |
| Personalis, Inc. | -74.95M |
| Adaptive Biotechnologies Corp. | -45.99M |
| 10X Genomics, Inc. | 136.05M |